MedPath

Leuprolin

Brand Name: Leuprolin

Generic Name: Leuprorelin Acetate

Active
Registration Number

DR-XY47491

Dosage Form

Lyophilized Powder for Injection (I.M./S.C.)

Issuance Date

October 26, 2021

Expiry Date

October 26, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength3.75mg
PackagingUSP Type I glass vial + Diluent

Classification

C
Classification
Prescription Drug (RX)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Leuprorelin AcetateActive
Monograph: Leuprolide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.